Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biomerica (BMRA) Interest & Investment Income (2016 - 2023)

Biomerica's Interest & Investment Income history spans 14 years, with the latest figure at $55632.0 for Q2 2023.

  • On a quarterly basis, Interest & Investment Income rose 666.28% to $55632.0 in Q2 2023 year-over-year; TTM through May 2023 was $133000.0, a 392.59% increase, with the full-year FY2023 number at $133000.0, up 392.59% from a year prior.
  • Interest & Investment Income hit $55632.0 in Q2 2023 for Biomerica, up from $36086.0 in the prior quarter.
  • Over the last five years, Interest & Investment Income for BMRA hit a ceiling of $55632.0 in Q2 2023 and a floor of $28.0 in Q3 2022.
  • Historically, Interest & Investment Income has averaged $18349.1 across 5 years, with a median of $8037.0 in 2020.
  • Biggest five-year swings in Interest & Investment Income: surged 7928.73% in 2019 and later tumbled 99.59% in 2022.
  • Tracing BMRA's Interest & Investment Income over 5 years: stood at $4488.0 in 2019, then soared by 77.87% to $7983.0 in 2020, then dropped by 13.37% to $6916.0 in 2021, then soared by 496.5% to $41254.0 in 2022, then skyrocketed by 34.85% to $55632.0 in 2023.
  • Business Quant data shows Interest & Investment Income for BMRA at $55632.0 in Q2 2023, $36086.0 in Q1 2023, and $41254.0 in Q4 2022.